AG
IMGN

Advisor Group’s Immunogen Inc IMGN Stock Holding History

Advisor Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$48K Buy
9,354
+331
+4% +$1.12K ﹤0.01% 3453
2019
Q3 		$21K Buy
9,023
+703
+8% +$1.87K ﹤0.01% 3944
2019
Q2 		$17K Buy
8,320
+432
+5% +$1.02K ﹤0.01% 4084
2019
Q1 		$21K Sell
7,888
-4,988
-39% -$21.6K ﹤0.01% 3961
2018
Q4 		$62K Sell
12,876
-269
-2% -$1.63K ﹤0.01% 3044
2018
Q3 		$124K Buy
13,145
+381
+3% +$3.66K ﹤0.01% 2589
2018
Q2 		$124K Sell
12,764
-409
-3% -$4.31K ﹤0.01% 2357
2018
Q1 		$139K Sell
13,173
-586
-4% -$5.79K ﹤0.01% 2267
2017
Q4 		$88K Buy
13,759
+2,110
+18% +$13K ﹤0.01% 2671
2017
Q3 		$88K Sell
11,649
-822
-7% -$5.46K ﹤0.01% 2514
2017
Q2 		$89K Buy
12,471
+4,281
+52% +$19.6K ﹤0.01% 2407
2017
Q1 		$32K Buy
8,190
+1,374
+20% +$4.01K ﹤0.01% 3042
2016
Q4 		$14K Buy
6,816
+831
+14% +$1.67K ﹤0.01% 3466
2016
Q3 		$16K Sell
5,985
-1,247
-17% -$3.63K ﹤0.01% 3305
2016
Q2 		$22K Buy
+7,232
New +$45.3K ﹤0.01% 3025

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Advisor Group's IMGN Position: Q4 2019 in Review

Advisor Group increased its Immunogen Inc (IMGN) stake by 3.7% in Q4 2019, buying an estimated $1.12K and bringing the position to 9,354 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #3453.

Advisor Group first reported a position in IMGN in Q2 2016 and has held it in 15 quarters since. The position peaked at $139K in Q1 2018. 191 funds tracked by Wall St. Rank hold IMGN as of Q4 2019.

  • Advisor Group held 9,354 shares of Immunogen Inc worth $48K as of Q4 2019.
  • Advisor Group bought 331 Immunogen Inc shares in Q4 2019, an estimated $1.12K.
  • Immunogen Inc made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3453 holding.
  • Advisor Group first reported a position in Immunogen Inc in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Immunogen Inc position peaked at $139K in Q1 2018.
  • 191 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.